Connect with us

Health

HPV vaccines for adults over age 26 may not be cost-effective – HSPH News

For immediate release: Thursday, March 11, 2021 Boston, MA – Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more…

Published

on

Article feature image

For immediate release: Thursday, March 11, 2021
Boston, MA Vaccinating adults age 26 and older against the human papillomavirus (HPV)the virus that causes more than 90% of cervicalcancers as well as several other cancersmay not be cost-effective, according to a new study led by researchers at the Harvard T.H. School of Public Health.
Our study found that the added health benefit of increasing the vaccination age limit beyond 26 years is minimal, and that the cost-effectiveness is much lower than…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending